Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blastoid Variant Mantle Cell Lymphoma”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06324994
What this trial is testing

Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.

Who this might be right for
Mantle Cell Lymphoma
Dalian Medical University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02427620
What this trial is testing

Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaMantle Cell LymphomaPleomorphic Variant Mantle Cell Lymphoma
M.D. Anderson Cancer Center 131
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Testing effectiveness (Phase 2)Temporarily pausedNCT05861050
What this trial is testing

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaMantle Cell LymphomaPleomorphic Variant Mantle Cell Lymphoma
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03946878
What this trial is testing

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaCCND1 Protein OverexpressionCD20 Positive+6 more
M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02869633
What this trial is testing

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Who this might be right for
Blastoid Variant Mantle Cell LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Follicular Lymphoma+6 more
Vanderbilt-Ingram Cancer Center 23